Genome Editing in Human iPS Cells to Study and Cure Disease
Human iPS (induced pluripotent stem) cells have the potential to allow us to study diseases in virtually any type of human cell, and develop cell transplantation-based therapies. Our team is developing and improving genome editing technology in iPS cells. We are developing novel isogenic iPS cell-based disease models, and correcting mutations in iPS cells from patients, a critical step in transplantation-based therapies. Our current focus is on diseases affecting cardiomyocytes and hepatocytes. →More
2020. 12. 9. Hitomi Yako joins the lab as an intern.
2020. 10. 30. We take lab photos while keeping social distance
2020. 10. 26. We hire a lab tech.
2020. 10. 1. Anri Saitoh starts her BS thesis in the lab.
2020. 9. 14. Dr. Miyaoka is highlighted in "IMIC".
2020. 9. 14. Diana Cifuentes joins the lab as an intern.
2020. 8. 2. Host summer special webinar for Hachimanyama Elementary School kids "Aim to be a PCR Master" (Online seminar).
2020. 5. 31. Host a public online science cafe "What is PCR?".